Treatment‐related calvarial lesions in pediatric brain tumor survivors. Issue 6 (14th April 2020)

• Record Type: Journal Article
• Authors: Wallace, David; Taylor, Douglas R.; Pan, Haitao; Hwang, Scott; Lucas, John T.; Klimo, Paul; Upadhyaya, Santhosh A.; Boop, Frederick A.
• Is Part Of: Pediatric blood & cancer. Volume 67:Issue 6(2020)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2020-04-14
• Subjects: calvarial lesion -- pediatric brain tumor -- radiation therapy; Tumors in children -- Periodicals; Blood -- Diseases -- Periodicals; Cancer in children -- Periodicals; 618.92
• DOI: 10.1002/pbc.28189
• Languages: English
• ISSNs: 1545-5009

Abstract

Abstract: Background: Despite improved survival, many pediatric brain tumor survivors receiving radiation therapy (RT) experience late effects. Procedure: To study calvarial lesions in this population, we retrospectively reviewed records of patients undergoing neurosurgical evaluation for calvarial bone lesions detected in posttreatment follow‐up imaging at St. Jude Children's Research Hospital. Primary tumor diagnosis, treatment, imaging, surgical intervention, and histopathology from patients with radiographic evidence of lesions followed for ≥2 years post‐RT were studied. Results: For 17 patients with 18 index lesions, median time to lesion manifestation was 2.34 years. Medulloblastoma patients developed lesions at a shorter interval from RT than ependymoma patients ( P = .05). Twelve of 14 lesions requiring surgery were benign fibro‐osseous or sclerotic. Two malignant lesions distinct from the primary tumor had genetic predisposition to malignancy. Conclusion: Most calvarial lesions arising post‐RT are benign and fibro‐osseous. Serial imaging is recommended, and high index of suspicion for malignant lesions is warranted for patients genetically predisposed to cancer.